Retour
Prix Emyria Ltd (EMYRF)
Graphique du cours de l'action EMYRF
EMYRF Gagner
Emyria Ltd
$0
0%
$0
À la fermeture : Jan 16, 16:00:00 GMT-5
$0
0%
$0
Post-Marché: Jan 16, 20:00:00 GMT-5
Earnings FAQ
Comment le bénéfice par action récent de EMYRF se compare-t-il aux attentes ?
Comment les revenus de Emyria Ltd EMYRF se sont-ils comportés au dernier trimestre ?
Quelle est l'estimation des revenus pour Emyria Ltd ?
Quel est le score de qualité des bénéfices pour Emyria Ltd ?
Quand Emyria Ltd publie-t-elle ses résultats ?
Quels sont les bénéfices attendus de Emyria Ltd ?
Emyria Ltd a-t-elle dépassé les attentes en matière de bénéfices ?
Statistiques clés
Clôture préc.
--
Prix d'ouverture
--
Plage de la journée
-
Plage de 52 semaines
-
Volume
--
Volume moyen
--
BPA (TTM)
--
Rendement en dividend
--
Capitalisation boursière
--
Qu’est-ce que EMYRF ?
Emyria Ltd. is a healthcare technology and services company. The company is headquartered in Leederville, Western Australia. The company went IPO on 2020-02-12. The firm is focused on delivering and developing treatments for mental health and select neurological conditions, guided by real-world data collected with patients across its wholly owned clinical service subsidiaries. Its pipeline comprises MDMA analogue drug development and commercialization of novel serotonin-releasing agents. Its Emyria Healthcare provides evidence-based treatment for patients not finding relief from conventional care, while also helping evaluate emerging new therapies like assisted therapy for post-traumatic stress disorder (PTSD) and assisted therapy for treatment-resistant depression. Its Emyria Data is a robust and ethically sourced real-world data gathered with patients and used to improve its therapy and drug development programs. Its Emyria’s Pipeline includes new psychedelic-assisted therapies and drug treatments for mental health and select neurological diseases.
Fonctionnalités
Stratégies de trading
Ressources
© 2025 Finture Development Limited. All rights reserved